Ro Khanna sold Ionis Pharmaceuticals Inc (NASDAQ: IONS)
Ro Khanna (D-CA), a U.S. Representative, has disclosed 1 trade in Ionis Pharmaceuticals Inc (IONS) since 2023, a single sale, worth an estimated $8K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).
The trade highlighted here is a sale: Ro Khanna sold $1,001 - $15,000 of Ionis Pharmaceuticals Inc (NASDAQ: IONS) on March 14, 2023. Since that trade, IONS is up +60.07% against the S&P 500 up +97.51%, an outperformance of -37.44%.
Data updated
Ro Khanna's IONS trades vs the price
IONS is up +60.07% since Ro Khanna sold on March 14, 2023, versus +97.51% for the S&P 500.
Performance since this trade
All Ro Khanna IONS trades
Ro Khanna & IONS trading FAQ
Is it legal for Ro Khanna to trade Ionis Pharmaceuticals Inc (IONS) stock?
Yes. Members of Congress are allowed to trade individual stocks, including Ionis Pharmaceuticals Inc (IONS), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.
When did Ro Khanna sell IONS?
Ro Khanna disclosed a sale of $1,001 - $15,000 of Ionis Pharmaceuticals Inc (IONS) on March 14, 2023, according to public STOCK Act filings.
How has IONS performed since Ro Khanna's trade?
Since Ro Khanna sold IONS on March 14, 2023, the stock is up +60.07%, versus +97.51% for the S&P 500 over the same period, an outperformance of -37.44%.
How soon must members of Congress disclose a trade?
Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.
Where can I see all congressional IONS trades?
Quantellect tracks every disclosed congressional trade in Ionis Pharmaceuticals Inc (IONS) on the Ionis Pharmaceuticals Inc congressional trading page, which aggregates filings across all members of Congress.
Ro Khanna's IONS tradesAll congressional filings for Ionis Pharmaceuticals IncRo Khanna's full profile
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.